Marex Group plc [MRX] vs Morgan Stanley [MS] Detailed Stock Comparison

Marex Group plc

NASDAQ
Loading...

Morgan Stanley

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Marex Group plc wins in 6 metrics, Morgan Stanley wins in 11 metrics, with 0 ties. Morgan Stanley appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricMarex Group plcMorgan StanleyBetter
P/E Ratio (TTM)9.0617.83Marex Group plc
Price-to-Book Ratio2.122.56Marex Group plc
Debt-to-Equity Ratio887.54438.54Morgan Stanley
PEG Ratio10.061.10Morgan Stanley
EV/EBITDA1.54N/AN/A
Profit Margin (TTM)10.14%22.49%Morgan Stanley
Operating Margin (TTM)14.55%34.12%Morgan Stanley
EBITDA Margin (TTM)14.55%34.12%Morgan Stanley
Return on Equity26.52%14.13%Marex Group plc
Return on Assets (TTM)1.09%1.16%Morgan Stanley
Free Cash Flow (TTM)$1.14B$-2.10BMarex Group plc
Dividend Yield2.01%2.15%Morgan Stanley
1-Year Return14.27%43.12%Morgan Stanley
Price-to-Sales Ratio (TTM)0.843.83Marex Group plc
Enterprise Value$1.33B$178.59BMorgan Stanley
EV/Revenue Ratio0.512.72Marex Group plc
Gross Profit Margin (TTM)38.83%N/AN/A
Revenue per Share (TTM)$37$41Morgan Stanley
Earnings per Share (Diluted)$3.31$8.84Morgan Stanley
Beta (Stock Volatility)N/A1.32N/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Marex Group plc vs Morgan Stanley Stock Performance Analysis

Loading Price Chart...

Marex Group plc
Morgan Stanley
Marex Group plc Stock Overview | Morgan Stanley Stock Overview

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Marex Group plc-3.05%-14.52%-17.19%-24.51%-20.45%-10.39%
Morgan Stanley-1.33%-1.90%6.25%9.98%56.65%26.69%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Marex Group plc14.27%53.37%53.37%53.37%53.37%53.37%
Morgan Stanley43.12%109.95%204.90%365.66%531.85%202.85%

News Based Sentiment: Marex Group plc vs Morgan Stanley

Marex Group plc

News based Sentiment: MIXED

October was a pivotal month for Marex, marked by both promising strategic partnerships aimed at expanding its clearing and digital asset capabilities, and a serious investigation into alleged accounting irregularities. This combination of positive and negative developments creates a complex investment picture, making it a significant month for the company's trajectory.

View Marex Group plc News Sentiment Analysis

Morgan Stanley

News based Sentiment: MIXED

October was a month of strategic positioning for Morgan Stanley, with expansions into cryptocurrency and investments in advisor education. While analyst sentiment is mixed and institutional ownership shows some bearish signals, the firm is proactively adapting to market changes, making it a significant month for investors to watch.

View Morgan Stanley News Sentiment Analysis

Performance & Financial Health Analysis: Marex Group plc vs Morgan Stanley

MetricMRXMS
Market Information
Market Cap i$2.19B$251.57B
Market Cap CategoryMid capMega cap
10 Day Avg. Volume i959,2305,110,020
90 Day Avg. Volume i1,074,1935,282,273
Last Close$28.25$155.98
52 Week Range$23.17 - $49.34$94.33 - $163.98
% from 52W High-42.74%-4.88%
All-Time High$49.34 (May 12, 2025)$163.98 (Sep 23, 2025)
% from All-Time High-42.74%-4.88%
Growth Metrics
Quarterly Revenue Growth0.13%0.11%
Quarterly Earnings Growth0.29%0.15%
Financial Health
Profit Margin (TTM) i0.10%0.22%
Operating Margin (TTM) i0.15%0.34%
Return on Equity (TTM) i0.27%0.14%
Debt to Equity (MRQ) i887.54438.54
Cash & Liquidity
Book Value per Share (MRQ)$14.14$61.59
Cash per Share (MRQ)$148.95$352.68
Operating Cash Flow (TTM) i$1.64B$-17,670,000,640
Levered Free Cash Flow (TTM) i$204.70M$12.80B
Dividends
Last 12-Month Dividend Yield i2.01%2.15%
Last 12-Month Dividend i$0.72$2.79

Valuation & Enterprise Metrics Analysis: Marex Group plc vs Morgan Stanley

MetricMRXMS
Price Ratios
P/E Ratio (TTM) i9.0617.83
Forward P/E i10.0619.87
PEG Ratio i10.061.10
Price to Sales (TTM) i0.843.83
Price to Book (MRQ) i2.122.56
Market Capitalization
Market Capitalization i$2.19B$251.57B
Enterprise Value i$1.33B$178.59B
Enterprise Value Metrics
Enterprise to Revenue i0.512.72
Enterprise to EBITDA i1.54N/A
Risk & Other Metrics
Beta iN/A1.32
Book Value per Share (MRQ) i$14.14$61.59

Financial Statements Comparison: Marex Group plc vs Morgan Stanley

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)MRXMS
Revenue/Sales i$865.70M$16.52B
Cost of Goods Sold i$544.70MN/A
Gross Profit i$321.00MN/A
Research & Development iN/AN/A
Operating Income (EBIT) i$239.30MN/A
EBITDA i$247.90MN/A
Pre-Tax Income i$98.00M$5.54B
Income Tax i$25.50M$1.17B
Net Income (Profit) i$72.50M$4.37B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)MRXMS
Cash & Equivalents i$2.61B$60.84B
Total Current Assets i$23.78BN/A
Total Current Liabilities i$21.77BN/A
Long-Term Debt i$1.54B$303.93B
Total Shareholders Equity i$1.05B$107.85B
Retained Earnings i$775.30M$107.65B
Property, Plant & Equipment i$86.80MN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)MRXMS
Operating Cash Flow iN/A$-67.29B
Capital Expenditures iN/A$-713.00M
Free Cash Flow iN/A$-24.69B
Debt Repayment iN/A$-20.85B
Common Stock Repurchase iN/A$-2.03B

Short Interest & Institutional Ownership Analysis

MetricMRXMS
Shares Short i2.35M16.22M
Short Ratio i2.383.52
Short % of Float i0.07%0.01%
Average Daily Volume (10 Day) i959,2305,110,020
Average Daily Volume (90 Day) i1,074,1935,282,273
Shares Outstanding i70.29M1.61B
Float Shares i51.28M1.21B
% Held by Insiders i0.25%0.24%
% Held by Institutions i0.75%0.63%

Dividend Analysis & Yield Comparison: Marex Group plc vs Morgan Stanley

MetricMRXMS
Last 12-Month Dividend i$0.72$2.79
Last 12-Month Dividend Yield i2.01%2.15%
3-Year Avg Annual Dividend i$0.24$3.10
3-Year Avg Dividend Yield i0.45%0.90%
3-Year Total Dividends i$0.72$9.31
Ex-Dividend DateAug 26, 2025Jan 31, 2025